Breaking News, Promotions & Moves

Neurocrine Biosciences Appoints Sanjay Keswani as Chief Medical Officer

Author Image

By: Charlie Sternberg

Associate Editor

Sanjay Keswani.

Neurocrine Biosciences Inc. has appointed Sanjay Keswani, M.D., to the company’s executive management team as Chief Medical Officer (CMO) effective June 2, 2025. Keswani, a physician-scientist who has more than 20 years of pharmaceutical industry experience with broad R&D expertise in multiple therapeutic areas, will lead the clinical development and medical affairs activities at Neurocrine. He succeeds Eiry W. Roberts, M.D., who has served as CMO for the past seven years and who wi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics